Mixed

Corporate strategies prioritizing shareholder value maximization over public health actively propagate non-communicable diseases through marketing, lobbying, supply chain expansion, and corporate social responsibility, creating an environment where unhealthy products are more available, desirable, and affordable.

To improve population health, policy must target corporate practices rather than just individual behavior. This involves supporting regulations on marketing, lobbying transparency, and supply chain accountability, particularly in low- and middle-income countries where market penetration is growing.